Clinical trial · Interventional
Sleep, Fatigue, and Dexamethosone in Children With Leukemia
Sleep, Fatigue, and Dexamethosone in Childhood Cancer
NCT00075101CI-TRIAL-00001648completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dexamethosone | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Study Cycle
- interventionNames
- Drug: Dexamethosone
Primary outcomes (1)
- measure
- Fatigue and sleep quality changes
- timeFrame
- 10 days
Secondary outcomes (2)
- measure
- Pharmacogenetics with dextamethasone use
- timeFrame
- 5 days
- measure
- Pharmacokinetics with dextamethasone use
- timeFrame
- 5 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 21 Years
Show eligibility criteria text
Children and adolescents with Leukemia, both genders
References
Publications (0)
Data not yet available
No reference posted for this study.